Suppressed RNA-polymerase 1 pathway is associated with benign multiple sclerosis.

by Anat Achiron, Anna Feldman, David Magalashvili, Mark Dolev, Michael Gurevich
Published 2012-01-01

Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis

by Anat Achiron, Itamar Grotto, Ran Balicer, David Magalashvili, Anna Feldman, Michael Gurevich
Published 2010-05-01

The Design, Development, and Testing of a Virtual Reality Device for Upper Limb Training in People With Multiple Sclerosis: Single-Center Feasibility Study

by Alon Kalron, Lior Frid, Iliya Fonkatz, Shay Menascu, Mark Dolev, David Magalashvili, Anat Achiron
Published 2022-09-01

Longitudinal relationships between disability and gait characteristics in people with MS

by Sapir Dreyer-Alster, Shay Menascu, Mark Dolev, Uri Givon, David Magalashvili, Anat Achiron, Alon Kalron
Published 2022-03-01

Cognitive function in multiple sclerosis: A long-term look on the bright side.

by Yermi Harel, Alon Kalron, Shay Menascu, David Magalashvili, Mark Dolev, Glen Doniger, Ely Simon, Anat Achiron
Published 2019-01-01

SARS‐CoV‐2 memory B and T cell profiles in mild COVID‐19 convalescent patients

by Michael Gurevich, Rina Zilkha-Falb, Polina Sonis, David Magalashvili, Shay Menascu, Shlomo Flechter, Mark Dolev, Mathilda Mandel, Anat Achiron
Published 2022-02-01

Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-a

by Shay Menascu, Roy Aloni, Mark Dolev, David Magalashvili, Keren Gutman, Sapir Dreyer-Alster, Franck Tarpin-Bernard, Ran Achiron, Gil Harari, Anat Achiron
Published 2021-12-01

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

by Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, David Magalashvili, Polina Sonis, Mark Dolev, Shay Menascu, Shlomo Flechter, Rina Falb, Michael Gurevich
Published 2021-05-01

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

by Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, David Magalashvili, Polina Sonis, Mark Dolev, Shay Menascu, Shlomo Flechter, Rina Falb, Michael Gurevich
Published 2021-04-01

Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.

by Anat Achiron, Joab Chapman, David Magalashvili, Mark Dolev, Mor Lavie, Eran Bercovich, Michael Polliack, Glen M Doniger, Yael Stern, Olga Khilkevich, Shay Menascu, Gil Hararai, Micharel Gurevich, Yoram Barak
Published 2013-01-01

Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis

by Izhak Levi, Michael Gurevich, Gal Perlman, David Magalashvili, Shay Menascu, Noam Bar, Anastasia Godneva, Liron Zahavi, Danyel Chermon, Noa Kosower, Bat Chen Wolf, Gal Malka, Maya Lotan-Pompan, Adina Weinberger, Erez Yirmiya, Daphna Rothschild, Sigal Leviatan, Avishag Tsur, Maria Didkin, Sapir Dreyer, Hen Eizikovitz, Yamit Titngi, Sue Mayost, Polina Sonis, Mark Dolev, Yael Stern, Anat Achiron, Eran Segal
Published 2021-04-01